Data / Form D filings / Biodel Inc
Biodel Inc: Form D filing
Biodel Inc, a pharmaceuticals company in Danbury, CT, filed a Form D with the SEC in 2012. The latest, on June 29, 2012, reports $18.5 million sold of a $18.5 million offering to 19 investors.
Find out what Biodel Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 SAW MILL ROAD, Danbury, CT, 06810
- Phone
- (203) 796-5000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1322505
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2012 | New notice | $18,500,002 | $18,500,002 | $0 | 19 | Jun 27, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel W. Lorber | Director | |
| Alan S. Krasner | Executive Officer | |
| Davey S. Scoon | Director | |
| Brian J.G. Pereira | Director | |
| Gerard J. Michel | Executive Officer | |
| Paul S. Bavier | Executive Officer | |
| Julie R. Brown | Director | |
| Barry S. Ginsberg | Director | |
| Ira W. Lieberman | Director | |
| Errol B. De Souza | Executive Officer, Director | |
| Erik S. Steiner | Executive Officer |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Jun 25, 2012 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biodel Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.